[Clinical experience with JO 475 suppositories].
D001565:Benzoates / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D002082:Butylamines / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D004338:Drug Combinations; D004341:Drug Evaluation; D005401:Fissure in Ano / Q000188:drug therapy; D006484:Hemorrhoids / Q000188:drug therapy*; D006801:Humans; D012003:Rectal Fistula / Q000188:drug therapy*; D013150:Spirostans / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D013488:Suppositories
D001565:Benzoates; D002082:Butylamines; D004338:Drug Combinations; D013150:Spirostans; D013488:Suppositories
Expertise clinique des suppositoires JO 475